DBV Technologies S.A. (DBVT)
NASDAQ: DBVT · Real-Time Price · USD
0.469
-0.020 (-4.15%)
Nov 22, 2024, 4:00 PM EST - Market closed
DBV Technologies Market Cap
DBV Technologies has a market cap or net worth of $54.27 million as of November 22, 2024. Its market cap has decreased by -71.24% in one year.
Market Cap
54.27M
Enterprise Value
17.89M
1-Year Change
-71.24%
Ranking
Category
Stock Price
$0.47
Market Cap Chart
Since October 22, 2014, DBV Technologies's market cap has decreased from $844.80M to $54.27M, a decrease of -93.58%. That is a compound annual growth rate of -23.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 49.00M | -73.30% |
| Dec 29, 2023 | 183.50M | -36.22% |
| Dec 30, 2022 | 287.70M | 63.47% |
| Dec 31, 2021 | 176.00M | -28.57% |
| Dec 31, 2020 | 246.40M | -68.16% |
| Dec 31, 2019 | 773.80M | 141.13% |
| Dec 31, 2018 | 320.90M | -73.54% |
| Dec 29, 2017 | 1.21B | -28.69% |
| Dec 30, 2016 | 1.70B | 22.23% |
| Dec 31, 2015 | 1.39B | 39.07% |
| Dec 31, 2014 | 1.00B | 18.43% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Xtant Medical Holdings | 54.92M |
| Theratechnologies | 54.90M |
| Kezar Life Sciences | 54.72M |
| Kronos Bio | 54.49M |
| Apyx Medical | 54.40M |
| Vor Biopharma | 54.25M |
| Prenetics Global | 54.00M |
| Singular Genomics Systems | 53.80M |